Expression of p53 Protein in Prostate Carcinoma and its Correlation with Gleason Grade

被引:2
作者
Wahid, Zakia [1 ]
Jaffer, Rozina [2 ]
Khalid, Sobia [3 ]
Khan, Haseeb Ahmed [1 ]
Riaz, Sabiha [1 ]
机构
[1] Fatima Mem Hosp, Dept Pathol, Lahore, Pakistan
[2] Rahber Med Coll, Dept Pathol, Lahore, Pakistan
[3] Univ Hlth Sci, Dept Pathol, Lahore, Pakistan
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2020年 / 30卷 / 06期
关键词
Prostate cancer; Immunohistochemistry; p53; protein; Gleason score; MUTANT P53;
D O I
10.29271/jcpsp.2020.6.643
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives; To determine the correlation of p53 expression with Gleason score in prostate cancer. Study Design: Descriptive study. Place and Duration of Study: Department of Pathology, Fatima Memorial Hospital, Lahore; from January 2014 to August 2016. Methodology: Thirty-seven samples of prostate carcinoma were graded using Gleason grading system. p53 expression was detected through routine immunohistochemical staining protocols and assessed semi-quantitatively using four-point scale score. The collected data was analysed statistically using Pearson's correlation coefficient. Results: Out of a sample of 37, high grade tumours were observed in 21 (57%) cases, making them the most prevalent type; while, p53 positive nuclear staining was observed in 26 (70%) cases. Within the high grade tumours, strong positive p53 expression was observed in 8 (38%) tumours; while, overexpression of p53 protein was seen in 7 (33%) cases. In contrast, overexpression of p53 was absent in low grade tumours. Conclusion: A statistically significant correlation was observed between p53 positive expression and high Gleason grade.
引用
收藏
页码:643 / 645
页数:3
相关论文
共 15 条
[1]  
Aziz Z, 2003, J Pak Med Assoc, V53, P350
[2]   When mutants gain new powers: news from the mutant p53 field [J].
Brosh, Ran ;
Rotter, Varda .
NATURE REVIEWS CANCER, 2009, 9 (10) :701-713
[3]   Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer [J].
Cooperberg, Matthew R. ;
Broering, Jeanette M. ;
Carroll, Peter R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1117-1123
[4]   Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[5]   The role of mutant p53 in human cancer [J].
Goh, Amanda M. ;
Coffill, Cynthia R. ;
Lane, David P. .
JOURNAL OF PATHOLOGY, 2011, 223 (02) :116-126
[6]  
Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.21254]
[7]  
Karaburun Paker S, 2001, Pathol Oncol Res, V7, P209
[8]  
Kaur H, 2016, ANN PATHOL LAB MED, V3, pA509
[9]  
Kehinde EO, 2008, CAN J UROL, V15, P3967
[10]   Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer [J].
Kluth, Martina ;
Harasimowicz, Silvia ;
Burkhardt, Lia ;
Grupp, Katharina ;
Krohn, Antje ;
Prien, Kristina ;
Gjoni, Jovisa ;
Hass, Thomas ;
Galal, Rami ;
Graefen, Markus ;
Haese, Alexander ;
Simon, Ronald ;
Huehne-Simon, Julia ;
Koop, Christina ;
Korbel, Jan ;
Weischenfeld, Joachim ;
Huland, Hartwig ;
Sauter, Guido ;
Quaas, Alexander ;
Wilczak, Waldemar ;
Tsourlakis, Maria-Christina ;
Minner, Sarah ;
Schlomm, Thorsten .
INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (06) :1369-1380